Cumba, Carmen G.

HRN: 17-34-49  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/10/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
03/10/2025
03/17/2025
IV
300mg
Q8
NON-HEALING WOUND
Waiting Final Action 
03/11/2025
CEFTRIAXONE 1G (VIAL)
03/11/2025
03/18/2025
IV
2g
OD
UTI
Waiting Final Action 
03/17/2025
CLINDAMYCIN 300MG (CAP)
03/17/2025
03/19/2025
ORAL
1200mg
Every 8hrs
Non Healing Wound
Waiting Final Action 
03/17/2025
CLINDAMYCIN 300MG (CAP)
03/17/2025
03/19/2025
ORAL
600mg
Every 8hrs
Non Healing Wound
Waiting Final Action 
03/18/2025
CLINDAMYCIN 300MG (CAP)
03/18/2025
03/25/2025
PO
600
TID
DM Foot
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: